Influence of PIK3CA mutations on breast cancer proliferation, lymphocyte infiltration and clinical outcome: Pooled analysis of 484 patients from three prospective multicentre GBG trials

Jank P, Loibl S, Fasching P, Karn T, Marme F, Mueller V, Schem C, Stickeler E, Lederer B, Denkert C (2019)

Publication Type: Conference contribution

Publication year: 2019

Journal

Annals of Oncology Elsevier

Publisher: OXFORD UNIV PRESS

City/Town: OXFORD

Conference Proceedings Title: ANNALS OF ONCOLOGY

Event location: Berlin DE

DOI: 10.1093/annonc/mdz095.014

Authors with CRIS profile

Peter Fasching Professur für Translationale Frauenheilkunde und Geburtshilfe

Involved external institutions

Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg DE Germany (DE) Universitätsklinikum Frankfurt am Main (KGU) DE Germany (DE) Charité - Universitätsmedizin Berlin DE Germany (DE) Universitätsklinikum Aachen (UKA) DE Germany (DE) Mammazentrum Hamburg MVZ GbR DE Germany (DE) GBG Forschungs GmbH (German Breast Group) DE Germany (DE) Philipps-Universität Marburg DE Germany (DE) Universitätsklinikum Hamburg-Eppendorf (UKE) DE Germany (DE)

How to cite

APA:

Jank, P., Loibl, S., Fasching, P., Karn, T., Marme, F., Mueller, V.,... Denkert, C. (2019). Influence of PIK3CA mutations on breast cancer proliferation, lymphocyte infiltration and clinical outcome: Pooled analysis of 484 patients from three prospective multicentre GBG trials. In ANNALS OF ONCOLOGY. Berlin, DE: OXFORD: OXFORD UNIV PRESS.

MLA:

Jank, P., et al. "Influence of PIK3CA mutations on breast cancer proliferation, lymphocyte infiltration and clinical outcome: Pooled analysis of 484 patients from three prospective multicentre GBG trials." Proceedings of the ESMO Breast Cancer, Berlin OXFORD: OXFORD UNIV PRESS, 2019.

BibTeX: Download